本贴相关题目 OG-12-CR-113 | GMATPrep-2007E2-CR-54 (LEEK)

00:00:00

The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.

Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the challenge made above?

ANo industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.
BClinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
CThere are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.
DAn existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
EMuch recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.

正确答案: B

大全-14-4的思路

[复制链接]

dorbear

楼主

发表于 2003-10-8 11:32:00 | 显示全部楼层

加强和削弱题最最重要的是找到结论，找到找不到论据其实对解题都没有大的关系；本题的结论就是20年不够；要加强它找一个为什么不够的理由就可以了，不论是提供了一个新的理由还是跟补充原来论据，只要有利于结论就可以了。

答案是B，二十年有一半时间在作临床，另一半才开始市场推广。（当然不够了，至少应延长10年把临床的部分补回来才合理）